ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,304Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 90

$830K Total Retail Price of All Prescriptions

Rank: 2 out of 90

447 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 447 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 447 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 8,086 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $138 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 545 343 1 12
TRAMADOL HCL 523 352 2 4
PRAVASTATIN SODIUM 519 379 3 27
SIMVASTATIN 483 359 4 11
AMLODIPINE BESYLATE 429 302 5 10
METOPROLOL TARTRATE 356 266 6 23
METFORMIN HCL 300 209 7 19
FUROSEMIDE 294 211 8 13
HYDROCHLOROTHIAZIDE 244 191 9 24
OMEPRAZOLE 220 166 10 28
RANITIDINE HCL 209 126 11 31
METHOTREXATE 193 64 12 2
POTASSIUM CHLORIDE 188 132 13 36
ZOLPIDEM TARTRATE 182 78 14 39
ALENDRONATE SODIUM 178 133 15 8
LOSARTAN POTASSIUM 174 126 16 38
CARVEDILOL 173 124 17 45
LEVOTHYROXINE SODIUM 157 115 18 16
COLCRYS 147 85 19 20
OXYCODONE-ACETAMINOPHEN 144 85 S2 20 21
LANTUS 144 75 20 60
ENDOCET 144 22 S2 20 41
PREDNISONE 141 73 23 1
HYDRALAZINE HCL 138 82 24 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 131 84 25 66
ALLOPURINOL 114 99 26 6
DIOVAN HCT 109 85 27 47
LOSARTAN-HYDROCHLOROTHIAZIDE 105 82 28 75
CYCLOBENZAPRINE HCL 103 27 R 29 22
KLOR-CON M20 99 79 30 76
CRESTOR 97 81 31 43
CLOPIDOGREL 97 81 31 49
IBUPROFEN 95 36 33 79
WARFARIN SODIUM 88 48 34 53
ATENOLOL 88 81 34 42
NEXIUM 88 31 34 17
PROAIR HFA 82 32 37 83
GLIPIZIDE 82 64 37 83
METOPROLOL SUCCINATE 80 47 39 32
GABAPENTIN 76 38 40 7
LANTUS SOLOSTAR 75 50 41 88
OXYCODONE HCL 74 23 S2 42 18
ISOSORBIDE MONONITRATE ER 73 69 43 65
LABETALOL HCL 73 45 43 90
ADVAIR DISKUS 71 21 45 57
BYSTOLIC 71 60 45 58
ATORVASTATIN CALCIUM 70 30 47 25
PANTOPRAZOLE SODIUM 68 55 48 59
NIFEDIPINE ER 65 49 49 98
GLYBURIDE 64 53 R 50 99
PLAVIX 63 57 51 62
QUINAPRIL HCL 63 29 51 101
VERAPAMIL ER 63 59 51 101
SPIRONOLACTONE 62 35 54 70
SPIRIVA 62 58 54 103
INDOMETHACIN 60 36 R 56 106
ULORIC 56 46 57 111
SINGULAIR 55 32 58 55
KLOR-CON M10 55 30 58 113
SERTRALINE HCL 55 31 58 113
INSULIN SYRINGE 54 19 61 117
HUMALOG 52 26 62 121
JANUVIA 52 42 62 121
LEVOFLOXACIN 50 34 64 123
VENTOLIN HFA 50 19 64 123
OXYBUTYNIN CHLORIDE 50 49 64 123
CELEBREX 50 22 64 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.